UptalPatel United States

Institution

Day 1 - Sunday April 14, 2024

Time	Session

9 a.m. 10:30 a.m.	Precise Phenotyping and Treatment SK01 HeatherReich Chairperson Heather.Reich@uhn.caCanadaUniversity of Toronto, University Health Network SebastiánJaurretche Chairperson sebastianjaurretche@hotmail.comArgentinaSanatorio Parque SA Deciphering the IGAN Cell Atlas JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deGermanyHeidelberg University Complement-mediated Kidney Diseases in the Era of Complement Inhibitors MarinaVivarelli Speaker marina.vivarelli@opbg.netItalyLaboratory of Nephrology, Bambino Gesù Children's Hospital CART-T JonathanHogan Speaker jonathan.hogan@cabalettabio.comCabaletta Bio New Targets to Reduce the Burden of Rare Kidney Diseases LauraMariani Speaker lmariani@umich.eduUnited StatesUniversity of Michigan Q and A Hall C4
10:30 a.m. 11 a.m.	Hitting the Four Hits: The Potential of Dual BAFF/APRIL Inhibition in IgA Nephropathy SPOT-O3 Jonathan Barratt Spotlight Speaker jb81@leicester.ac.ukUnited KingdomUniversity of Leicester, Leicester, UK Spotlight Stage 1 (exhibition hall)
11 a.m. 12 p.m.	Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria) PL2 AgnesFogo Chairperson agnes.fogo@vanderbilt.eduUnited States GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology My Story VictoriaGray Speaker vwright_03@yahoo.comUnited States CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture Obiageli EuniceNnodu Speaker oennodu@gmail.comNigeriaUniversity of Abuja Hall A
3 p.m. 4 p.m.	New Tools to Study Kidney Disease SK02 RafaelMaldonado Chairperson ramaldonado@gmail.comArgentina ReikoInagi Chairperson inagi-r@m.u-tokyo.ac.jpJapanThe University of Tokyo Graduate School of Medicine Understanding Glomerular Damage: From Spatial Transcriptomics to Chip Technology LauraPerin Speaker LPerin@chla.usc.eduUnited States Spatial Metabolomics of Kidney Disease TonRabelink Speaker a.j.rabelink@lumc.nlNetherlandsLUMC Constructing an Epigenetic Network for Diabetic Nephropathy Sam El-Osta Speaker sam.el-osta@baker.edu.auAustraliaBaker Heart and Diabetes Institute Q and A Hall E
4 p.m. 4:30 p.m.	Potential Role of Anti-CD38 Therapy in Autoimmune Kidney Diseases like Lupus Nephritis SPOT-07 BradRovin Spotlight Speaker rovin.1@osu.eduUnited StatesThe Ohio State University UptalPatel Spotlight Speaker uptal@hibio.comUnited States Spotlight Stage 1 (exhibition hall)
4:30 p.m. 5:30 p.m.	Kidney Transplantation: State of the Art. ISN-TTS Joint Session CHAL1002 CarlosDiaz Chairperson cdiaz@cemic.edu.arArgentinaSección Nefrología, Departamento de Medicina Interna, Instituto Universitario CEMIC. GermaineWong Chairperson germaine.wong@health.nsw.gov.auAustraliaUniversity of Sydney MarianoArriola Chairperson marianoarriola@hotmail.comArgentinaSAT, SAN, Facultad de Medicina (UNL) Quality and Safety in Kidney Transplantation WanessaClemente Speaker wanclemente@yahoo.com.brBrazilUniversidade Federal de Minas Gerais Machine Perfusion of the Kidney HenryPleass Speaker henry.pleass@sydney.edu.auAustraliaSpecialty of Surgery, Westmead Hospital, Universit Menopause and Kidney Transplantation SofiaAhmed Speaker sofia.ahmed@ahs.caCanadaUniversity of Alberta Q and A Hall D

Day 2 - Monday April 15, 2024

Time	Session

9 a.m. 10:30 a.m.	Hot Digests of Kidney Inflammation and Immunity: ISN-JSN Joint Session LF2002 AlejandraQuevedo Smuclir Chairperson alejandra.s.quevedo@gmail.comArgentinaSAN CarmenTzanno Branco Martins Chairperson tzanno@gmail.comBrazilSLANH, ISN SaoriNishio Chairperson saorin@med.hokudai.ac.jpJapan Update of Glomerulonephritis FernandoFervenza Speaker fervenza.fernando@mayo.eduUnited StatesMayo Clinic Inflammation and Metabolic Kidney Disease JunWada Speaker junwada@okayama-u.ac.jpJapanOkayama University A Novel Treatment Targeting Kidney Inflammation Maria JoseSoler Speaker mjsoler01@gmail.comSpainHospital del Vall d´Hebron Controlling Kidney Inflammation Through the Nervous System ShinjiTanaka Speaker shitanaka@m.u-tokyo.ac.jpJapanDivision of Nephrology and Endocrinology, the University of Tokyo Hospital Q and A Hall C3
11 a.m. 12 p.m.	Plenary Session 3: Generative AI Revolution in Medicine (Michal Rosen-Zvi, Israel) PL3 Jose VicenteSanchez Polo Chairperson visanpolo@gmail.comGuatemalaRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH) MegJardine Chairperson meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia Generative AI Revolution in Medicine MichalRosen-Zvi Speaker ROSEN@il.ibm.comIsraelhttps://research.ibm.com/ Acceptance Speech by Awardee (Schrier Award), with Tasnuva Sarah Kashem (UK) and Farnaz Nobi (Bangladesh) Mohammad Shakib Uz ZamanArefin Speaker shakib04@yahoo.comBangladesh Hall A
3 p.m. 4 p.m.	Late Breaking Clinical Trials Session LBCT AlessiaFornoni Chairperson afornoni@med.miami.eduUnited StatesUniversity of Miami MichelleRheault Chairperson rheau002@umn.eduUnited StatesUniversity of Minnesota Predicting the Risks of Kidney Failure and Death in Adults With Moderate-to-severe Chronic Kidney Disease (KDpredict) PietroRavani Free Communication pravani@ucalgary.caCanadaUniversity of Calgary Plasma Exchange in ANCA Associated Vasculitis GN: Update After Pexivas Wladimir MietekSzpirt Speaker wladimir.mietek.szpirt.01@regionh.dkDenmarkRigshospitalet, University of Copenhagen, Dept. of Nephrology, Denmark, Senior Research Consultant EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY: INTERIM RESULTS FROM THE PHASE 3 APPLAUSE-IgAN STUDY DanaRizk Free Communication drizk@uabmc.eduUnited StatesUniversity of Alabama at Birmingham SPARSENTAN VS IRBESARTAN IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN): SUBGROUP ANALYSES OF 2-YEAR RESULTS FROM THE PIVOTAL PHASE 3 PROTECT TRIAL Jonathan Barratt Free Communication jb81@leicester.ac.ukUnited KingdomUniversity of Leicester, Leicester, UK PREGNANCY AMONG WOMEN ON CHRONIC DIALYSIS : THE FRENCH COHORT CécileCouchoud Free Communication cecile.couchoud@biomedecine.frFranceREIN registry, Agence de la biomédecine, France Hall A	Transplant-Onconephrology CHAL04 DarioRoccatello Chairperson dario.roccatello@unito.itItaly GayatriNair Chairperson gnair1@northwell.eduUnited StatesNorthwell Health, NY MarianoArriola Chairperson marianoarriola@hotmail.comArgentinaSAT, SAN, Facultad de Medicina (UNL) Use of Immunotherapy in Patients With Organ Transplants NaokaMurakami Speaker nmurakami1@bwh.harvard.eduUnited StatesBrigham and Women\'s Hospital, Harvard Medical S Transplantation Outcomes in Recipients with History of Cancer GermaineWong Speaker germaine.wong@health.nsw.gov.auAustraliaUniversity of Sydney Novel Strategies for Enhanced Organ Preservation during Machine Perfusion TobiasHuber Speaker t.huber@uke.deGermanyUniversity Medical Center Hamburg-Eppendorf Q and A Hall E
4:30 p.m. 5:30 p.m.	Designing Smart Clinical Trials SK05 DebbieGipson Chairperson debbie.gipson@nih.govUnited StatesNational Institutes of Health/NIDDK Jonathan Barratt Chairperson jb81@leicester.ac.ukUnited KingdomUniversity of Leicester, Leicester, UK Patients Subphenotyping: The Example of Diabetic Kidney Disease John CijiangHe Speaker cijiang.he@mssm.eduUnited StatesIcahn School of Medicine at Mount Sinai Power of AI to Develop Data-driven Early Detection, Diagnosis, and Management of Kidney Disease LauraMariani Speaker lmariani@umich.eduUnited StatesUniversity of Michigan Targeted Approaches in Clinical Trial Design HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands Q and A Hall D

Day 3 - Tuesday April 16, 2024

Time	Session

9 a.m. 10:30 a.m.	Clinical Management of Glomerulonephritis (GN) SK06 Juan ManuelMejia Vilet Chairperson jmmejia@hotmail.comMexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán ValeriaAlberton Chairperson vgalberton@gmail.comArgentinaHospital Fernandez/ Hospital El Cruce Updates on IgAN Management HernánTrimarchi Speaker htrimarchi@hotmail.comArgentinaHOSPITAL BRITÁNICO DE BUENOS AIRES Membranous GN Classification and Management PierreRonco Speaker pierreronco@yahoo.frFranceHôpital Tenon MPGN Updates SanjeevSethi Speaker sethi.sanjeev@mayo.eduUnited StatesMayo Clinic Managing Vasculitis RobertaFenoglio Speaker roberta.fenoglio@unito.itItalyOspedale San Giovanni Bosco Q and A Hall A
12:30 p.m. 1:30 p.m.	Rare and Orphan Diseases SK07 AliGharavi Chairperson ag2239@cumc.columbia.eduUnited States RobertaFenoglio Chairperson roberta.fenoglio@unito.itItalyOspedale San Giovanni Bosco VaninaVazquez Chairperson azquezvanina64@gmail.comArgentina Alport Spectrum Disorders (Genetics) MoumitaBarua Speaker moumita.barua@uhn.caCanada Genetics of Nephrotic Syndrome SimoneSanna-Cherchi Speaker ss2517@cumc.columbia.eduUnited StatesColumbia University Lupus Nephritis Transcriptomics Across Time and Space AnaMalvar Speaker avmperrin@yahoo.com.arArgentinaHospotal Fernandez, Organizacion Medica de Investigacion Q and A Hall E

Pre-Congress - Saturday April 13, 2024

Time	Session

9 a.m. 11 a.m.	Renal Pathology Course: New Insights in Glomerular Disease: Part 1 PATH1 CarmenAvila Casado Chairperson carmen.avila-casado@uhn.caCanadaUniversity of Toronto, UHN ValeriaAlberton Chairperson vgalberton@gmail.comArgentinaHospital Fernandez/ Hospital El Cruce WesamIsmail Chairperson wesam_ismail@yahoo.comEgyptHead of Pathology Department, Beni Suef University Updates in Genetic Testing in Renal Disease PATH1-01 DanicaGalešić Ljubanović Speaker danica.ljubanovic@mef.hrCroatiaUniversity of Zagreb, School of Medicine, Department of Pathology and Dubrava University Hospital, Zagreb, Croatia Classification of Lupus PATH1-02 AgnesFogo Speaker agnes.fogo@vanderbilt.eduUnited States New Insights in Membranous Nephropathy PATH1-03 SanjeevSethi Speaker sethi.sanjeev@mayo.eduUnited StatesMayo Clinic Amyloidosis Update PATH1-04 WesamIsmail Speaker wesam_ismail@yahoo.comEgyptHead of Pathology Department, Beni Suef University Q and A PATH1-05 Hall C1	Primer Course in Glomerular Disease: A Case-Based Approach: Foundation in Glomerular Diseases & Rapidly Progressive Glomerulonephritis GN1 AdrianLiew Chairperson draliew2@gmail.comSingaporeMount Elizabeth Novena Hospital, Singapore HeatherReich Chairperson Heather.Reich@uhn.caCanadaUniversity of Toronto, University Health Network HernánTrimarchi Chairperson htrimarchi@hotmail.comArgentinaHOSPITAL BRITÁNICO DE BUENOS AIRES Jonathan Barratt Chairperson jb81@leicester.ac.ukUnited KingdomUniversity of Leicester, Leicester, UK Histophysiology of the Glomerulus SoniaChicano Speaker sonialchicano@yahoo.comPhilippinesISN Overview of Immunosuppression DanaRizk Speaker drizk@uabmc.eduUnited StatesUniversity of Alabama at Birmingham Genetic Testing in Glomerular Diseases KeishaGibson Speaker keisha_gibson@med.unc.eduUnited StatesUniversity of North Carolina at Chapel Hill, USA Approach to RPGN ArennJauhal Speaker Arenn.Jauhal@uhn.caCanada Case Presentation and Discussion 1 HernánTrimarchi Speaker htrimarchi@hotmail.comArgentinaHOSPITAL BRITÁNICO DE BUENOS AIRES Hall E
11:30 a.m. 1:30 p.m.	Primer Course in Glomerular Disease: A Case-Based Approach: Nephrotic Syndrome GN2 AdrianLiew Chairperson draliew2@gmail.comSingaporeMount Elizabeth Novena Hospital, Singapore HeatherReich Chairperson Heather.Reich@uhn.caCanadaUniversity of Toronto, University Health Network HernánTrimarchi Chairperson htrimarchi@hotmail.comArgentinaHOSPITAL BRITÁNICO DE BUENOS AIRES Jonathan Barratt Chairperson jb81@leicester.ac.ukUnited KingdomUniversity of Leicester, Leicester, UK Approach to Nephrotic Syndrome Chee KayCheung Speaker ckc15@leicester.ac.ukUnited KingdomUniversity of Leicester Case Presentation and Discussion 2 MarinaVivarelli Speaker marina.vivarelli@opbg.netItalyLaboratory of Nephrology, Bambino Gesù Children's Hospital Case Presentation and Discussion 3 KeishaGibson Speaker keisha_gibson@med.unc.eduUnited StatesUniversity of North Carolina at Chapel Hill, USA Case Presentation and Discussion 4 HeatherReich Speaker Heather.Reich@uhn.caCanadaUniversity of Toronto, University Health Network Hall E
1 p.m. 2:30 p.m.	Sharing Expertise to Support the Set-up of Renal Registries: The Global Situation and Inspiration from Established Registries in Latin America: Part 1 SHARE RR1 FergusCaskey Chairperson Fergus.Caskey@bristol.ac.ukUnited KingdomUniversity of Bristol, UK MariaPippias Chairperson maria.pippias@bristol.ac.ukUnited KingdomUniversity of Bristol Welcome MasaomiNangaku Speaker mnangaku@m.u-tokyo.ac.jpJapan Introduction of SharE-RR FergusCaskey Speaker Fergus.Caskey@bristol.ac.ukUnited KingdomUniversity of Bristol, UK Introduction of SharE-RR Toolkit MariaPippias Speaker maria.pippias@bristol.ac.ukUnited KingdomUniversity of Bristol Current State of Registries Worldwide, 2023 ISN-GKHA AminuBello Speaker aminu1@ualberta.caCanadaUniversity of Alberta The History of Renal Registries In Latin America: 1950 - Current (Including PAHO Collaboration) MariaGonzalez Speaker registro@slanh.netUruguaySLANH The Argentinian Renal Registry GuillermoRosa Diez Speaker guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology Sala 1
2:15 p.m. 4:15 p.m.	Primer Course in Glomerular Disease: A Case-Based Approach: Nephritic Syndrome GN3 AdrianLiew Chairperson draliew2@gmail.comSingaporeMount Elizabeth Novena Hospital, Singapore HeatherReich Chairperson Heather.Reich@uhn.caCanadaUniversity of Toronto, University Health Network HernánTrimarchi Chairperson htrimarchi@hotmail.comArgentinaHOSPITAL BRITÁNICO DE BUENOS AIRES Jonathan Barratt Chairperson jb81@leicester.ac.ukUnited KingdomUniversity of Leicester, Leicester, UK Approach to Nephritic Syndrome HernánTrimarchi Speaker htrimarchi@hotmail.comArgentinaHOSPITAL BRITÁNICO DE BUENOS AIRES Case Presentation and Discussion 5 LizLightstone Speaker l.lightstone@imperial.ac.ukUnited KingdomImperial College London Case Presentation and Discussion 6 Jonathan Barratt Speaker jb81@leicester.ac.ukUnited KingdomUniversity of Leicester, Leicester, UK Case Presentation and Discussion 7 AdrianLiew Speaker draliew2@gmail.comSingaporeMount Elizabeth Novena Hospital, Singapore Hall E
4:30 p.m. 6 p.m.	WCN'24 Opening Ceremony and Plenary Session 1: The Origin of the Universe (Daniel de Florian, Argentina) OCPL1 ISN President's Address MasaomiNangaku Speaker mnangaku@m.u-tokyo.ac.jpJapan Tribute to Stewart Cameron Welcome by WHO Director of Non-Communicable Diseases Dr Bente Mikkelsen Welcome by Dr. Marina Papaginovic, SAN President; Dr. Guillermo Rosa Diez, WCN Local Organising Group Chair; and Dr. Jorge Rico, SLANH President and WCN Local Organizing Group co-Chair GuillermoRosa Diez Speaker guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology JorgeRico Speaker jorgericof@yahoo.comColombia MariaPapaginovic Leiva Speaker drapapaginovicleiva@gmail.comArgentina Welcome by Minister of Health for Buenos Aries Dr Fern Welcome by SPWG Chair Alessia Fornoni AlessiaFornoni Speaker afornoni@med.miami.eduUnited StatesUniversity of Miami The Origin of the Universe DanielDe Florian Speaker deflo@unsam.edu.arArgentinaUniversidad Nacional de San Martin Acceptance Speech: Hamburger Award AdeeraLevin Speaker alevin@providencehealth.bc.caCanadaUniversity of British Columbia and Providence Health Care Hall A